Published in J Psychoactive Drugs on June 01, 2007
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol (2010) 1.71
Pharmacotherapy of amphetamine-type stimulant dependence: an update. Drug Alcohol Rev (2013) 1.29
Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users. Addict Behav (2009) 1.04
Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction (2014) 0.89
Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients. J Subst Abuse Treat (2015) 0.78
Factorial structure of the Brief Symptom Inventory (BSI)-18 among Chinese drug users. Drug Alcohol Depend (2013) 0.77
Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder. Ann N Y Acad Sci (2016) 0.76
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction (2013) 2.23
Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res (2007) 2.02
Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry (2005) 1.94
Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat (2008) 1.89
The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction (2008) 1.82
HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial. J Acquir Immune Defic Syndr (2014) 1.79
A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcohol Clin Exp Res (2008) 1.77
Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA (2010) 1.71
The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment. J Gen Intern Med (2010) 1.51
Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology (2003) 1.44
Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. Am J Psychiatry (2005) 1.37
Associations of housing status with substance abuse treatment and service use outcomes among veterans. Psychiatr Serv (2010) 1.25
The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend (2004) 1.24
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). J Stud Alcohol Drugs (2013) 1.22
The content and clinical utility of psychiatric advance directives. Psychiatr Serv (2005) 1.16
Study results from the Clinical Trials Network's first 10 years: where do they lead? J Subst Abuse Treat (2010) 1.16
Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters. J Opioid Manag (2012) 1.10
Brief motivational feedback improves post-incarceration treatment contact among veterans with substance use disorders. Drug Alcohol Depend (2003) 1.07
Women in addictions treatment: comparing VA and community samples. J Subst Abuse Treat (2002) 1.01
Integrating tobacco cessation treatment into mental health care for patients with posttraumatic stress disorder. Am J Addict (2006) 0.97
A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin. Drug Alcohol Depend (2005) 0.95
Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years. Drug Alcohol Depend (2007) 0.94
An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology (2013) 0.92
Integrating smoking cessation into mental health care for post-traumatic stress disorder. Clin Trials (2007) 0.92
Methadone medical maintenance in primary care. An implementation evaluation. J Gen Intern Med (2005) 0.90
Personality disorders in veterans with posttraumatic stress disorder and depression. J Trauma Stress (2004) 0.90
The Alcohol Use Disorders Identification Test (AUDIT) predicts alcohol withdrawal symptoms during inpatient detoxification. J Addict Dis (2002) 0.89
A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. J Addict Dis (2005) 0.88
Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder. Nicotine Tob Res (2012) 0.87
Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010. Drug Alcohol Depend (2012) 0.87
Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. J Subst Abuse Treat (2006) 0.84
Open trial of injectable risperidone for methamphetamine dependence. J Addict Med (2009) 0.84
Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence. J Am Pharm Assoc (2003) (2005) 0.83
Quetiapine for the treatment of cocaine dependence: an open-label trial. J Clin Psychopharmacol (2008) 0.83
Extended-release naltrexone and harm reduction counseling for chronically homeless people with alcohol dependence. Subst Abus (2015) 0.82
Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment. Am J Public Health (2003) 0.82
Can an immunoassay become a standard technique in detecting oxycodone and its metabolites? J Anal Toxicol (2005) 0.82
A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res (2015) 0.82
Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease. J Alzheimers Dis (2009) 0.81
A randomized trial of self-management and psychoeducational group therapies for comorbid chronic posttraumatic stress disorder and depressive disorder. J Trauma Stress (2007) 0.80
Mood disorders and risk of lung cancer in the EAGLE case-control study and in the U.S. Veterans Affairs inpatient cohort. PLoS One (2012) 0.79
Ghrelin concentrations reflect body mass index rather than feeding status in obese girls. Pediatr Res (2007) 0.79
Longitudinal analysis of the relationship between PTSD symptom clusters, cigarette use, and physical health-related quality of life. Qual Life Res (2012) 0.78
Smoking intensity and severity of specific symptom clusters in posttraumatic stress disorder. J Trauma Stress (2012) 0.78
Comparative safety of benzodiazepines and opioids among veterans affairs patients with posttraumatic stress disorder. J Addict Med (2013) 0.78
Survey of providers' attitudes toward integrating smoking cessation treatment into posttraumatic stress disorder care. Psychol Addict Behav (2012) 0.78
Preliminary findings: Contingency management targeting psycho-stimulant use results in secondary decreases in smoking for severely mentally ill adults. Am J Addict (2013) 0.78
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study. Am J Geriatr Psychiatry (2003) 0.78
Tobacco use treatment in primary care patients with psychiatric illness. J Am Board Fam Med (2014) 0.77
Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients. J Psychoactive Drugs (2006) 0.77
Medication-assisted treatment for opioid addiction: methadone and buprenorphine. J Food Drug Anal (2013) 0.77
Dopamine and depression. Arch Gen Psychiatry (2007) 0.75
Pharmacokinetic profile of an oral loading dose of divalproex sodium during acute alcohol withdrawal. J Clin Psychopharmacol (2006) 0.75
Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice". J Acquir Immune Defic Syndr (2014) 0.75
Morphine after combat injury and post-traumatic stress disorder. N Engl J Med (2010) 0.75
Tobacco use data questioned in veterans study. Arch Gen Psychiatry (2010) 0.75
Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. J Addict Med (2016) 0.75
High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System. J Addict Med (2017) 0.75
Pay for performance. J Healthc Qual (2009) 0.75